Intelligence Β· Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors β phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text β searchable for business development and competitive intelligence.
-
indibulin
Alaunos Therapeutics
Advanced Cancer
1 trial -
interceptive orthodontic treatments
NORTHWEST BIOTHERAPEUTICS INC
Malocclusion
1 trial -
iridoid enriched mixed fruit beverage
International Peace Maternity and Child Health Hospital
Oxidative Stress
1 trial -
ketamine
Summit Therapeutics
Multiple Sclerosis
1 trial -
limonene containing massage oil
United Therapeutics Europe Ltd
Breast Cancer
1 trial -
locally manufactured adoptive cellular therapy (ACT) product
Iovance Biotherapeutics B.V.
Malignant Pleural Effusion
1 trial -
mesenchymal stem cells
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Peripheral Vascular Disease
1 trial -
mifepristone + fluvastatin
CORCEPT THERAPEUTICS INC
Healthy Subjects
1 trial -
milatuzumab
United Therapeutics Europe Ltd
Lupus Erythematosus, Cutaneous
1 trial -
mitoxantrone hydrochloride
Karyopharm Therapeutics Inc
Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities
1 trial -
mitragynine
BRIGHT MINDS BIOSCIENCES INC.
Safety and Tolerability in Healthy Subjects
1 trial -
neratinib
PUMA BIOTECHNOLOGY, INC.
Tumors
1 trial -
neratinib
PUMA BIOTECHNOLOGY, INC.
Healthy
5 trials -
olaparib
United Therapeutics Europe Ltd
Advanced Cancer
1 trial -
oral palifosfamide tris
Alaunos Therapeutics
Advanced Cancer
1 trial -
oral treprostinil
United Therapeutics Europe Ltd
Raynaud's Phenomenon
1 trial -
pTVG-HP with rhGM-CSF
United Therapeutics Europe Ltd
Prostate Cancer
1 trial -
palifosfamide-tris
Alaunos Therapeutics
Advanced Solid Tumors
1 trial -
palifosfamide-tris
Alaunos Therapeutics
Malignancy
1 trial -
placebo
Lakefront Biotherapeutics NV
Healthy
1 trial -
rAAVrh74.MHCK7.DYSF.DV
Sarepta Therapeutics
Dysferlinopathy
1 trial -
rHuPH20
HALOZYME THERAPEUTICS, INC.
Healthy Volunteers
1 trial -
rHuPH20
HALOZYME THERAPEUTICS, INC.
Risk Factors for or a Diagnosis of Osteoporosis
1 trial -
rQNestin
Candel Therapeutics
Malignant Glioma of Brain
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1β3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync β verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources